Companies: 10,795·Total market cap: $144.5T
ABVC BioPharma, Inc.

ABVC BioPharma, Inc.

ABVCNASDAQHealthcare● Active
$1.34
+$0.00(+0.29%)
Market Cap$19473708
P/E Ratio
52W High$5.48
52W Low$0.88
Overview

ABVC BioPharma, Inc. (ABVC) Revenue

Annual & quarterly revenue history · segment & region breakdown

ABVC · revenue · updated Jun 9, 2026

Core revenue metrics

ABVC BioPharma, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
16 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · ABVC BioPharma, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
ABVC revenue by year · ABVC revenue history · ABVC annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income ABVC BioPharma, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

ABVC BioPharma, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from ABVC BioPharma, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

ABVC revenue · 4 questions

ABVC's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

ABVC revenueABVC annual revenuewhat is ABVC revenueABVC TTM revenue

Source: FMP · ABVC BioPharma, Inc. SEC filings · GAAP · ABVC BioPharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026